Disodium n-ethyl-n-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium
RxNorm 1807340
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1807340 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: disodium n-ethyl-n-4-((4-(ethyl((3-sulfophenyl)methyl)amino)phenyl)(2-sulfophenyl)methylene-2,5-cyclohexadien-1-ylidene)-3-sulfobenzenemethanaminium.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.